Determination of piribedil in pharmaceutical formulations by micellar electrokinetic capillary chromatography

被引:9
|
作者
Yardimci, C [1 ]
Süslü, I [1 ]
Özaltin, N [1 ]
机构
[1] Univ Hacettepe, Fac Pharm, Dept Analyt Chem, TR-06100 Ankara, Turkey
关键词
piribedil; capillary electrophoresis; micellar electrokinetic chromatography; pharmaceuticals;
D O I
10.1007/s00216-004-2539-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A fast and simple micellar electrokinetic capillary chromatographic method was developed for the analysis of piribedil in pharmaceutical formulations. The effects of buffer concentration, buffer pH, sodium dodecyl sulphate (SDS) concentration, organic modifier, applied voltage and injection time were investigated. Optimum results were obtained with a 50 mM borate buffer at pH 8.0 containing 50 mM SDS by using a fused silica capillary (50 mum internal diameter, 72 cm effective length). The sample was injected hydrodynamically for 4 s at 50 mbar pressure and the applied voltage was +30 kV. The detection wavelength was set at 205 nm. Diflunisal was used as an internal standard. The analysis was performed at 25 degreesC and the total run time was 14 min. The method was suitably validated with respect to linearity range, limit of detection and quantification, precision, accuracy, specificity and robustness. The linear calibration range was 5-100 mug mL(-1) and the limit of detection was determined as 1 mug mL(-1). The method developed was successfully applied to the determination of piribedil in pharmaceutical formulations. The results were compared with a spectrophotometric method reported in the literature and no significant difference was found statistically.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 50 条
  • [21] Determination of plasma heparin by micellar electrokinetic capillary chromatography
    Zhou, XM
    Liu, JW
    Zhang, ME
    Chen, SJ
    TALANTA, 1998, 46 (04) : 757 - 760
  • [22] Determination of rofecoxib, in the presence of its photodegradation product, in pharmaceutical preparations by micellar electrokinetic capillary chromatography
    Emirhan Nemutlu
    Nuran Özaltın
    Sacide Altınöz
    Analytical and Bioanalytical Chemistry, 2004, 378 : 504 - 509
  • [23] Application of micellar electrokinetic capillary chromatography for the determination of nifedipine and its degradation product in pharmaceutical preparations
    Özaltin, N
    Nemutlu, E
    Yardimci, C
    Süslü, I
    ANALYTICAL LETTERS, 2003, 36 (02) : 371 - 387
  • [24] Determination of rofecoxib, in the presence of its photodegradation product, in pharmaceutical preparations by micellar electrokinetic capillary chromatography
    Nemutlu, E
    Özaltin, N
    Altinöz, S
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2004, 378 (02) : 504 - 509
  • [25] Simultaneous determination of atorvastatin and ezetimibe from combined pharmaceutical products by micellar electrokinetic capillary chromatography
    Szekely-Szentmiklosi, Blanka
    Hancu, Gabriel
    Szekely-Szentmiklosi, Istvan
    Kovacs, Bela
    Kelemen, Hajnal
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (01)
  • [26] Validation of a micellar electrokinetic capillary chromatography method for the determination of imidurea, methyl and propylparabens in a pharmaceutical ointment
    Baalbaki, B
    Blanchin, MD
    Fabre, H
    ANALYTICA CHIMICA ACTA, 2002, 463 (01) : 15 - 20
  • [27] MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY
    SEPANIAK, MJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 191 : 112 - ANYL
  • [28] MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY
    SEPANIAK, MJ
    BURTON, DE
    MASKARINEC, MP
    ACS SYMPOSIUM SERIES, 1987, 342 : 142 - 151
  • [29] MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY
    SEPANIAK, MJ
    BURTON, DE
    BALCHUNAS, AT
    POWELL, AC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 69 - ANYL
  • [30] Simultaneous determination of HIV-protease inhibitors lamivudine and zidovudine in pharmaceutical formulations by micellar electrokinetic chromatography
    Sekar, R
    Azhaguvel, S
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) : 653 - 660